4 February 2008

Phase 2 clinical trial results for Huperzine A

Neuro-Hitech reports cognitive improvement from phase two clinical trial of Huperzine a in Alzheimer’s disease patients
Central Daily: 1 February 2008
Neuro-Hitech, Inc. a New York-based biopharmaceutical company focused on developing innovative drugs for the treatment of neurodegenerative diseases, today announced top-line results from the double-blind part of a phase 2 clinical trial of Huperzine A in mild to moderate Alzheimer's disease (AD) patients…. > full story

No comments:

Post a Comment

Alzheimer's Australia NSW

Alzheimer's Australia NSW
Alzheimer's Australia NSW

Latest headlines from Library News

Library News

Total Pageviews